Market Cap | ₹3,206Cr |
ROE | 7.19% |
P/E Ratio(TTM) | 50.69 |
EPS(TTM) | 5.13 |
P/B Ratio | 2.54 |
Dividend Yield | 0.31% |
Industry P/E | 35.33 |
Book Value | 102.37 |
Debt to Equity | 0.61 |
Face Value | 2 |
Parent Organisation | Hikal Limited |
Managing Director | Mr. Sameer Hiremath |
NSE Symbol | HIKAL |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 69.65 | ||
Neuland Laboratories | NA (0.00%) | 108.88 | ||
Jubilant Pharmova | NA (0.00%) | 37.52 | ||
Acutaas Chemicals | NA (0.00%) | 62.26 |